Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

Presentation EuroPCR 2022

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Presenter: Ajay J. Kirtane, Michel Azizi

May 17, 2022

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Conference News HRS 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Todd Neale

May 10, 2019

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Todd Neale

September 21, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Daily News

肾脏去神经支配试验在很大程度上会受到意外偏倚的影响

Todd Neale

January 19, 2016

News Daily News

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

Todd Neale

January 19, 2016

News Daily News

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

Todd Neale

January 19, 2016

Presentation TCT 2014

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka

September 16, 2014

Presentation TCT 2014

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud

September 16, 2014

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Advertisement

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Registry Data Hint at MACE Benefit With Renal Denervation

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

肾脏去神经支配试验在很大程度上会受到意外偏倚的影响

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Updates and Status of the Boston Scientific Vessix Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content